Basics Cerus Corporation Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety. IPO Date: January 31, 1997 Sector: Healthcare Industry: Health Care Equipment and Supplies Market Cap: $248.51M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 2.74% Avg Daily Range (30 D): $0.04 | 3.09% Avg Daily Range (90 D): $0.05 | 3.19% Institutional Daily Volume Avg Daily Volume: .74M Avg Daily Volume (30 D): 1.06M Avg Daily Volume (90 D): 1.27M Trade Size Avg Trade Size (Sh.): 178 Avg Trade Size (Sh.) (30 D): 193 Avg Trade Size (Sh.) (90 D): 211 Institutional Trades Total Inst.Trades: 941 Avg Inst. Trade: $1.28M Avg Inst. Trade (30 D): $.93M Avg Inst. Trade (90 D): $1.09M Avg Inst. Trade Volume: .24M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.27M Avg Closing Trade (30 D): $.93M Avg Closing Trade (90 D): $.93M Avg Closing Volume: 225.79K         News Jul 17, 2024 @ 12:21 PM ASML Reports Q2 Results, Joins Spirit Airlines And... Source: Avi Kapoor Jul 17, 2024 @ 10:03 AM Why Bloom Energy Group Shares Are Trading Higher B... Source: Avi Kapoor Apr 8, 2024 @ 12:24 PM Perion Network Cuts Sales Outlook, Joins Range Res... Source: Avi Kapoor Mar 21, 2024 @ 3:40 AM Cathie Wood's Ark Invest Sells Another Tranche Of ... Source: Benzinga Neuro Mar 14, 2024 @ 3:41 AM Cathie Wood's Ark Invest Sells Coinbase Shares As ... Source: Benzinga Neuro Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.1 $-.04 $-.01 Diluted EPS $-.1 $-.04 $-.01 Revenue $ 206.06M $ 31.04M $ 114.08M Gross Profit $ $ $ Net Income / Loss $ -18.99M $ -7.72M $ -2.56M Operating Income / Loss $ -12.1M $ -5.85M $ -1.45M Cost of Revenue $ $ $ Net Cash Flow $ -1.65M $ -.78M $ -1.85M PE Ratio